CONTINUE TO SITE
OR WAIT 15 SECS
The Public Health Systems Research Institute (PHRI) and Novo Nordisk Pharma (Thailand) Co. have sign
Eisai Co. has announced the launch of Pariet® S”(pharmaceutical requiring guidance), which is highly
Singapore-based biopharmaceutical company Specialised Therapeutics (ST) has announced the Australian registrat
A research team led by Dr Der-Yang Cho, Superintendent of China Medical University Hospital (Taiwan), in colla
RevolKa Ltd., a venture-backed biotech company providing a cutting-edge artificial intelligence (AI)-driven pr
Administered through the National Health and Medical Research Council’s (NHMRC) Clinical Trials and
ClavystBio, a life sciences investor and venture builder established by Temasek, and the Agency for Science, T
The Hong Kong University of Science and Technology (HKUST) has announced that its School of Engineering
WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), has ki
Japan-headquartered Fujifilm Corporation's Life Sciences Group companies, a portfolio of businesses offering p
APAC'S ALLIANCE-DRIVEN BIOTECH BOOM
Partnerships are a cornerstone of the biotech innovation process. COVID-19 acted as a catalyst, accelerating collaboration across the sector and prompting partnerships between established players for the first time. Since then, biotech alliances have become more diverse, frequent, and strategically important, especially in the Asia-Pacific (APAC) region. Biotech partnerships of APAC differ in a variety of ways from most global collaborations, primarily due to the unique geopolitical and socio-economic landscape of the region. The region has innovation hubs like Japan and South Korea as well as large, high-growth markets such as China and India. As China rapidly scales its biopharma capabilities, it is becoming both a key market and an innovator. This transformation has redefined regional deal-making, shifting the focus from technology transfer to co-development, shared commercialisation, and strategic alignment. APAC biotech deals are no longer early-stage R&D plays, they are beginning to span the full lifecycle, from bench to bedside, including commercialisation milestones. Let’s explore further the APAC's wave of regional biotech partnerships during the first five months of this calendar year ie. from January to May 2025.
Internnational Oligonucleotides and Peptides Conference 2025
teknoscienze
info@iopc-tks.com https://www.iopc-tks.com/Prague
HIMSS54 European Health Conference and Exhibition 2025
HIMSS
info@iito.de https://gkc.himss.org/event-himss-europeParis
Antibody Engineering G Therapeutics Europe 2025
Informa Connect
lifesciencescustomerrelations@informa.com https://informaconnect.com/antibody-engineering-europe/Basel
